Ex vivo drug sensitivity screening predicts response to temozolomide in glioblastoma patients and identifies candidate biomarkers

ABSTRACT: To investigate in situ-in vitro molecular correspondence and the relationship between in vitro and patient response to temozolomide (TMZ)

ORGANISM(S): Homo sapiens

PROVIDER: GSE232173 | GEO | 2023/08/23

REPOSITORIES: GEO